17 years' of EBRT plus HDR brachytherapy boost in high risk localized prostate cancer patients

被引：0
|
作者：
Vigneault, E. [1 ]
Carignan, D. [2 ]
Magnan, S. [1 ]
Froment, M. [1 ]
Foster, W. [1 ]
Aubin, S. [1 ]
Lavallee, M. [1 ]
Lacroix, F. [1 ]
Cantin, A. [1 ]
Poulin, E. [1 ]
Martin, A. [1 ]
机构：
[1] Univ Laval, CHU Quebec, Quebec City, PQ, Canada
[2] Univ Laval, CHU Quebec, Ctr Rech, Axe Oncol, Quebec City, PQ, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 158卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0101
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [41] APOPTOSIS AND SENESCENCE IN LOCALIZED PROSTATE CANCER TISSUES TREATED WITH HDR-BT BOOST WITH RADIOTHERAPY (EBRT) AND ADT
    Chebra, Imen
    Carignan, Damien
    Perigny, Martine
    Martin, Andre-Guy
    Foster, William
    Vigneault, Eric
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S33 - S33
  • [42] Apoptosis and Senescence in Localized Prostate Cancer Tissues Treated With HDR-BT Boost With Radiotherapy (EBRT) and ADT
    Chebra, I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E258 - E258
  • [43] Late sequelae in 400 prostate cancer patients treated with combined EBRT and HDR-brachytherapy
    Boehmer, D
    Deger, S
    Dinges, S
    Loening, SA
    Budach, V
    [J]. PROGRESS IN RADIO-ONCOLOGY VII, PROCEEDINGS, 2001, : 731 - 732
  • [44] HDR brachytherapy boost improves metastatic free survival in high and very-high risk prostate cancer
    Visus, I.
    Barco, A.
    Obeso, J.
    Barrado, M.
    Sola, A.
    Villafranca, E.
    Fuentemilla, N.
    Pellejero, S.
    Navarrete, P.
    Martinez, E.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S536 - S537
  • [45] HDR brachytherapy as monotherapy or a boost for high risk prostate cancer: 5 year single center data
    Novikov, S.
    Kanaev, S.
    Novikov, R.
    Ilin, N.
    Gotovchikova, M.
    Girshovitch, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S202 - S203
  • [46] HDR Brachytherapy in the Management of High-Risk Prostate Cancer
    Masson, Susan
    Persad, Raj
    Bahl, Amit
    [J]. ADVANCES IN UROLOGY, 2012, 2012
  • [47] LDR versus HDR brachytherapy boost in prostate cancer patients - a retrospective analysis
    Rodda, S.
    Murray, L.
    Bottomley, D.
    Bownes, P.
    Wilkinson, C.
    Adiotomre, E.
    Al-Qaisieh, B.
    Dugdale, E.
    Hulson, O.
    Mason, J.
    Smith, J.
    Henry, A. M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S587 - S587
  • [48] CLINICAL OUTCOME OF INTERSTITIAL HIGH DOSE RATE (HDR) BRACHYTHERAPY plus EXTERNAL BEAM RADIOTHERAPY (EBRT) FOR EARLY STAGE PROSTATE CANCER
    Aluwini, S.
    van Rooij, P.
    Jansen, P.
    Praag, J.
    Bangma, C.
    Kirkels, W.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S24 - +
  • [49] High dose rate brachytherapy as a boost for the treatment of localized prostate cancer
    Phan, Thinh P.
    Syed, A. M. Nisar
    Puthawala, Ajmel
    Sharma, Anil
    Khan, Farhan
    [J]. JOURNAL OF UROLOGY, 2007, 177 (01): : 123 - 127
  • [50] Ten Year Survival and Quality of Life after Combined High-Dose-Rate Brachytherapy Boost (HDR-BT) and External Beam Radiotherapy (EBRT) for Localized Prostate Cancer
    Kirste, S.
    Wiedenmann, N.
    Henne, K.
    Bruggmoser, G.
    Knippen, S.
    Volegova, N.
    Schultze-Seemann, W.
    Heinemann, F.
    Grosu, A. L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S374 - S374
12345